Publication | Closed Access
Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases
160
Citations
21
References
2011
Year
Breast OncologyMedicinePhase Ii StudyPathologyBreast CancerCancer TreatmentOncologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1